StockTipsArenaBeta

BUY Nephrocare Health Services Limited — ICICI Securities

BUYNephrocare Health Services Limited
Nephrocare Health Services share price target & all analyst calls

byICICI SecuritiesHorizon: 1 year18 Jun 2026via Institutional / Brokerage Research

Entry₹723.35Inferred
Target₹900
Total upside +24.42%
Stop lossNot given
CMP₹596.457h ago
Active-17.54%+50.89%upside left 8 mo left
Follow ICICI Securities for new calls(67% target hit, 1027 closed calls)Get alertsWatch NEPHROPLUS for new buy/sell callsGet alertsSee 3 other Long-term calls on NEPHROPLUSSee 274 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 11:54 pm IST
21 supporting7 neutral4 opposing
Supports the BUY call (21)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·12 Oct · 2w ago

Neutral / worth noting (7)

Q2 FY27 results scheduled — board meets 03 Nov 2026

BSE · Board Meeting·In 10 days

(opens in new tab)

Nephrocare Health Services Block Deal: Investors likely to sell 9% stake at ₹705/share

NewsCnbc-Tv18·24 Sept · 4w ago

(opens in new tab)
Weighs against the BUY call (4)

Nephrocare shares tumble 5% | What’s driving the decline?

NewsLivemint·24 Sept · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Nephrocare Health Services

All analyst calls on Nephrocare Health Services

More from ICICI Securities

Every call and its outcome